Pathogenic T helper (T h )17 cells are key mediators of autoimmune diseases such as uveitis and its animal model, experimental autoimmune uveitis (EAU). However, the contribution of microRNAs (miRs) to the intrinsic control of pathogenic T h 17 cells in EAU remains largely unknown. Here, we have reported that miR-223-3p was significantly up-regulated in interphotoreceptor retinoid-binding protein-specific T h 17 cells, and its expression was enhanced by IL-23-signal transducer and activator of transcription 3 signaling. Knockdown of miR-223-3p decreased the pathogenicity of T h 17 cells in a T-cell transfer model of EAU. Mechanistic studies showed that miR-223-3p directly repressed the expression of forkhead box O3 (FOXO3), and FOXO3 negatively regulated pathogenic T h 17 cell responses partially via suppression of IL-23 receptor expression. Thus, our results reveal an important role for miR-223-3p in autoreactive T h 17 cell responses and suggest a potential therapeutic avenue for
T helper (T h )17 cells are critically involved in the pathogenesis of various autoimmune disorders, including uveitis and its animal model, experimental autoimmune uveitis (EAU) (1) (2) (3) . T h 17 cells require IL-6 and TGF-b for their development and IL-23 for their effector functions (4) (5) (6) . Increasing data demonstrate that T h 17 cells induced by IL-23 are more pathogenic than those induced by IL-6 and TGF-b (7) . IL-23 stabilizes pathogenic T h 17 cell phenotype by increasing expression of IL-23 receptor (IL-23R) and endows T h 17 cells with pathogenic effector functions (8, 9) . IL-23 also drives the expression of granulocytemacrophage colony-stimulating factor (GM-CSF) (10, 11) , which is crucial for the pathogenicity of T h 17 cells. Although much is known about the key factors that drive T h 17 cell differentiation and pathogenicity, very little is known about the cell-intrinsic mechanisms that regulate pathogenic function of T h 17 cells.
MicroRNAs (miRs) are noncoding single-stranded RNAs of about 22 nt that regulate gene expression at the post-transcriptional level via translational repression or mRNA degradation (12) . miRs have been revealed to control dynamic aspects of autoimmunity (13) . Moreover, published works have characterized a series of miRs involved in uveitis pathogenesis (14) (15) (16) . Regarding the role of miRs in T h 17 cells in uveitis, miR-155 has been shown to promote T h 17 responses by targeting E26 transformation specific-1 (Ets-1) in CD4 + T cells from patients with active Behçet's disease (BD) (17) . Furthermore, Chang et al. (18) reported that miR-20a-5p suppressed T h 17 cell responses by targeting oncostatin M and C-C motif chemokine ligand 1 in CD4 + T cells in patients with active Vogt-Koyanagi-Harada disease. However, the contributions of miRs to pathogenic T h 17 cells induced by IL-23 in uveitis are still largely unknown.
The forkhead box O (FOXO) family (FOXO1, 3, 4, and 6) of transcription factors plays important roles in innate and adaptive immune responses (19) . For example, FOXO3 has been shown to promote the expression of forkhead box protein 3 (Foxp3) in regulatory T (T reg ) cells (20) . Moreover, Caroline et al. reported that FOXO3 enhanced pathogenic T h 1 cell differentiation by inducing eomeseodermin expression in experimental autoimmune encephalomyelitis (EAE) (21) . In FOXO1 2/2 FOXO3 2/2 T cells, genes associated with T h 17 cell differentiation were up-regulated and IL-17 production was increased (22) , suggesting FOXO3 may be involved in regulating the production of IL-17. However, whether and how FOXO3 is involved in induction of pathogenic T h 17 cells remains unknown.
In this study, we showed that miR-223-3p was significantly up-regulated in interphotoreceptor retinoid-binding protein (IRBP)-specific T h 17 cells in EAU. miR-223-3p positively regulated pathogenic T h 17 cell responses by directly targeting FOXO3, and FOXO3 inhibited IL-17 production partially via suppression of IL-23R expression. Furthermore, knockdown of miR-223-3p in T cells dramatically reduced the severity of EAU and decreased autoreactive T h 17 cell percentages. Our study reveals a previously unknown Tcell-intrinsic miR pathway that promotes autoreactive T h 17 cells and identifies the miR-223-3p-FOXO3-IL-23R axis as a potential therapeutic target in uveitis.
MATERIALS AND METHODS

Mice
Pathogen-free female C57BL/6 (B6) (10-wk-old) mice were purchased from Vital River Laboratory Animal Technology (Beijing, China). All animal experiments conformed to the Statement for the Use of Animals in Ophthalmic and Vision Research (Association for Research in Vision and Opthalmology, Rockville, MD, USA), and the protocol was approved by the Institutional Animal Care and Use Committee of Tianjin Medical University.
Antibodies, cytokines, and peptides
FITC-conjugated or phycoerythrin-conjugated antibodies against mouse IL-17, IFN-g, CD4, CD11c, and Foxp3 were purchased from BioLegend (San Diego, CA, USA). Antibody to FOXO3 was purchased from Cell Signaling Technology (Danvers, MA, USA), and antibody to b-actin was purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Recombinant murine IL-12, IL-23, IL-4, and GM-CSF were purchased from R&D Systems (Minneapolis, MN, USA). A truncated form of IRBP peptide [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] (aa 1-20 of human IRBP) was synthesized and purified by Sangon Biotech (Shanghai, China). Mycobacterium tuberculosis strain H37RA was obtained from Difco Laboratories (Detroit, MI, USA). Pertussis toxin was purchased from MilliporeSigma (Burlington, MA, USA). WP1066 (Calbiochem, San Diego, CA, USA) was dissolved in DMSO for storage and use.
T-cell preparation and differentiation
CD4 + T cells were purified from the spleen or draining lymph nodes of IRBP 1-20 -immunized B6 mice or naive mice by positive selection using a combination of FITC-conjugated anti-mouse CD4 antibodies and anti-FITC antibody-coated microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), followed by separation using an autoMACS Separator Column (Miltenyi Biotec) according to the manufacturer's protocol. The purity of the isolated cells was determined by flow cytometric analysis using phycoerythrin-conjugated anti-CD4 antibodies.
CD4 + T cells were isolated from immunized B6 mice and cocultured with irradiated antigen-presenting cells (APCs) and immunized antigen (10 mg/ml) alone (T h 0 cells) or in the presence of IL-12 (10 ng/ml) for T h 1 cell polarization or IL-23 (20 ng/ ml) for T h 17 cell polarization. Forty-eight hours later, cells were collected for further analysis.
Generation of bone marrow-derived dendritic cells
Dendritic cells (DCs) were generated from B6 mice as previously described in refs. 23 and 24. Briefly, bone marrow cells from B6 mice were isolated and cultured for 6 d in complete Roswell Park Memorial Institute (RPMI) medium 1640 containing 10 ng/ml GM-CSF (R&D Systems) and 10 ng/ml IL-4 (R&D Systems). DCs were enriched using magnetically activated cell sorting separation and then treated with miR-223-3p mimics or control mimics.
EAU induction and evaluation
For active induction of EAU, B6 mice were injected subcutaneously over 6 spots on the tail base and flank with the emulsion containing equal volumes of 200 mg of IRBP 1-20 in PBS and complete Freund's adjuvant (CFA) and intraperitoneally with 350 ng of pertussis toxin (MilliporeSigma). For adoptive transfer, CD4 + T cells transfected with miR-223-3p inhibitor or control inhibitor were stimulated with 10 mg/ml of IRBP 1-20 for 48 h in the presence of APCs under T h 17 cell polarizing conditions. Then, activated T-cell blasts were separated by density gradient centrifugation (Ficoll; GE Healthcare, Waukesha, WI, USA) and injected into naive B6 mice.
To examine mice for clinical signs of EAU by indirect fundoscopy, the pupils were dilated using 1.25% phenylephrine hydrochloride ophthalmic solution and 0.5% tropicamide. Fundoscopic grading of disease was performed using the scoring system previously reported in Thurau et al. (25) . Histopathological evaluation was performed on eye sections at the end of the experiment, and disease was graded on the basis of cellular infiltration and structural changes as previously reported in Zhang et al. (26) .
Transfection miR-223-3p mimics and control mimics, as well as miR-223-3p inhibitor and control inhibitor, were designed and synthesized by Gene Pharma (Suzhou, China). DCs and autoreactive CD4 + T cells were transfected with these RNAs at the final concentration of 180 and 300 nM, respectively, using Lipofectamine 2000 Reagent (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer's instructions. The FOXO3specific small interfering RNAs (siRNAs) were obtained from Gene Pharma, and the following sequences were used: for FOXO3 siRNA, 59-UGAUGAUCCACCAAGAGCUCUUGCC-39(sense) and 59-GGCAAGAGCUCUUGGUGGAUCAUCA-39 (antisense); for control siRNA, 59-UUCUCCGAACGUGUCA-CGUTT-39 (sense) and 59-ACGUGACACGUUCGGAGAATT-39 (antisense). plasmid pReceiver-Lv201-IL-23R was purchased from Gene-Copoeia (Rockville, MD, USA). Four micrograms of the pReceiver-Lv201-IL-23R or the control plasmid were used for each transfection.
Lentivirus infection
The overexpression lentiviral plasmid pReceiver-Lv201-FOXO3 was purchased from GeneCopoeia. Lentivirus was produced according to the manufacturer's instructions. CD4 + T cells isolated from EAU mice were infected with the concentrated lentivirus by spinning at 1000 g for 90 min. Subsequently cells were cultured at 37°C for 24 h, followed by T h 17 cell polarizing induction. After 48 h, culture supernatants were collected for ELISA detection and cells were lysed for real-time quantitative RT-PCR (qRT-PCR) analysis. 
Luciferase reporter assay
miR microarray, gene expression and real-time qRT-PCR analysis
Total RNA was extracted from naive or autoreactive CD4 + T cells using Trizol reagent (Thermo Fisher Scientific) according to the manufacturer's protocol. Purified RNA was prepared, according to the manufacturer's instructions (CapitalBio, Beijing, China) for miR array analysis with an 8 3 60 K miR Microarray Kit (Agilent Technologies, Santa Clara, CA, USA). Microarray data were analyzed by the GeneSpring GX software (Agilent Technologies). The Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/) was sought to obtain gene expression profiles in uveitis patients and healthy volunteers, and GSE70403, GSE17114, GSE61399 and GSE10080 were selected for exploring the correlation of FOXO3 and the pathogenic T h 17 pathway. Real-time qRT-PCR was performed using Sybr Green Master Mix and an ABI 7900 HT Sequence Detection System (both from Thermo Fisher Scientific). For miR analysis, reverse transcription and real-time qRT-PCR primers for miRs and U6 small nuclear RNA are listed in Table 1 . Relative miR expression was calculated using the 2 2DDCt cycle threshold method with the expression of U6 as an internal control. For mRNA analysis, the gene-specific primers for real-time qRT-PCR are listed in Table 2 . The relative expression level of mRNA was normalized to that of endogenous gene glyceraldehyde-3-phosphate dehydrogenase using the method previously described.
Flow cytometric analysis and ELISA
For intracellular cytokine staining, aliquots of T cells were stimulated with 50 ng/ml of phorbol myristic acetate, 1 mg/ml of ionomycin, and 1 mg/ml of brefeldin A (MilliporeSigma) for 4 h; then they were fixed, permeabilized overnight, and intracellularly stained with antibodies. Stained cells were analyzed on a flow cytometer (FACS Calibur; BD Biosciences, San Jose, CA, USA). FlowJo software (TreeStar, Ashland, OR, USA) was used to analyze the acquired data.
The cytokines in the culture supernatants were detected with commercially available ELISA kits (R&D Systems).
Western blot analysis
EL4 T cells were lysed with RIPA buffer (Solarbio, Beijing, China) containing PMSF (Solarbio) and phosphataseprotease inhibitor cocktail (Cell Signaling Technology). The protein concentration was measured with a Bicinchoninic Acid Assay Kit (Solarbio). Equal amounts of protein (20 mg) were loaded and resolved on SDS-polyacrylamide gel and transferred onto PVDF membrane. The membranes were blotted with antibodies specific for FOXO3 (Cell Signaling Technology) or b-actin (Santa Cruz Biotechnology) and a horseradish peroxidase-linked secondary antibody. The bands were obtained and analyzed as we previously described in Xiao et al. (24) .
Statistical analysis
All the experiments were repeated 3 times or more. The results are presented as means 6 SD, or means 6 SEM. Statistical analysis was performed by an unpaired, 2-tailed Student's t test, 1-or 2way ANOVA. A value of P , 0.05 was considered statistically significant.
RESULTS
miR-223-3p is up-regulated in IRBP-specific T h 17 cells
Given that autoreactive CD4 + T cells play a major role in autoimmune uveitis, we performed microarray analysis detecting the miR expression profiles between naive and autoreactive CD4 + T cells. As shown in Fig. 1A , the results highlighted up-regulated expression of 2 distinct miRs (miR-223-3p and miR-210-3p) in autoreactive CD4 + T cells, which was further confirmed by real-time qRT-PCR analysis (Fig. 1B ). In addition, the data also revealed significantly up-regulated expression of miR-223-3p and miR-210-3p in CD4 + T cells from the CFA + IRBPimmunized group compared with that in CFA-immunized Additionally, we found that IL-23 induced the expression of miR-223-3p and miR-210-3p in a dosedependent manner. (Fig. 1J, K) . Signal transducer and activator of transcription 3 (STAT3) is one of the major downstream molecules of IL-23 signaling (28) . IL-23 activates STAT3 in T h 17 cells from patients with BD (29) . To further determine whether STAT3 is involved in the regulation of miR-223-3p expression, autoreactive T cells from EAU mice were pretreated with different doses of WP1066, a STAT3 inhibitor, and then cocultured with APC in the presence of IL-23. As shown in Fig. 1L , WP1066 reversed IL-23-induced up-regulation of miR-223-3p in a dose-dependent manner (Fig. 1L) , indicating a correlation between IL-23-STAT3 signaling and miR-223-3p.
miR-223-3p positively regulates pathogenic T h 17 cell responses
We next determined whether miR-223-3p and miR-210-3p directly regulated T h 17 cell responses in vitro. T cells isolated from immunized B6 mice were transfected with miR-223-3p, miR-210-3p mimics, or control mimics and then cocultured with APC in the presence of immunized antigen under T h 17 cell polarizing conditions. As shown in Fig. 2A , B, ELISA assay revealed that miR-223-3p overexpression significantly promoted IL-17 secretion, whereas miR-210-3p overexpression had no significant effect on this cytokine. Because of the stronger effect of miR-223-3p on IL-17 production, we next focused on the role of miR-223-3p in the regulation of autoreactive T h 17 cells. Further analysis revealed that miR-223-3p overexpression significantly increased the percentages of 
GGCAAAGCAGACCCTCAAACT TGAGAGCAGATTTGGCAAAGG IL-17-producing T cells compared with that in the control group (26.3 vs. 17.6%, Fig. 2C ). In addition, miR-223-3p overexpression significantly increased the expression of some pathogenic T h 17 cell-related genes-IL-17, retinoic acid receptor-related orphan receptor-gt (ROR-gt), IL-22, GM-CSF, and IFN regulatory factor 4-at 48 h after stimulation with IRBP [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . There was a very small and statistically insignificant increase in IL-23R expression at 48 h after stimulation (Fig. 2D, E) . However, the kinetic data revealed significantly increased expression of IL-23R at 72 h after stimulation (Fig. 2F) .
To further confirm the role of miR-223-3p in pathogenic T h 17 cells, CD4 + T cells isolated from EAU mice were transfected with miR-223-3p inhibitor or control inhibitor. As shown in Fig. 2G , miR-223-3p was indeed silenced by miR-223-3p inhibitor, which was accompanied by a dramatically decreased IL-17 production ( Fig. 2H) and T h 17 cell percentages (19.1 vs. 27.9%, Fig. 2I ). In addition, miR-223-3p knockdown significantly decreased the expression of IL-17, ROR-gt, IL-22, IL-1 receptor 1 (IL-1R1), IL-23R, and GM-CSF ( Fig. 2J ). Collectively, these findings suggest that miR-223-3p is an important regulator that positively modulates the pathogenicity of T h 17 cells in vitro.
miR-223-3p promotes DC-driven T h 17 responses
Previous studies have shown that miR-223 2/2 DCs exhibited decreased ability to drive T h 17 cell responses in EAE (30) . To determine whether miR-223-3p in DCs affects IRBP-specific T h 17 cell responses in EAU, we cocultured miR-223-3p mimic-or control mimic-transfected DCs with autoreactive T cells from immunized B6 mice under T h 17 cell polarizing conditions in the presence of immunized antigen. As shown in Fig. 2K -M, the percentages of antigen-specific IL-17-producing T cells and the production of IL-17 were significantly increased in autoreactive T cells cocultured with miR-223-3p mimic-transfected DCs compared with those in T cells cocultured with control mimic-transfected DCs. These data indicate that DC-intrinsic miR-223-3p contributes to pathogenic T h 17 cell responses in EAU.
IL-1b, IL-6, and IL-23 produced by DCs are critically involved in pathogenic T h 17 cell development (31, 32) . Given the effect of DC-intrinsic miR-223-3p on T h 17 cell responses, we next examined the role of miR-223-3p in regulation of T h 17 cell polarizing cytokine expression in DCs. DCs pretreated with miR-223-3p mimics or control mimics were stimulated with LPS for 24 h and then were subjected to real-time qRT-PCR analysis. As indicated in Fig. 2N , overexpression of miR-223-3p resulted in significantly enhanced IL-1b and IL-23 expression, suggesting miR-223-3p contributes to the creation of a favorable environment for pathogenic T h 17 cell development.
Silencing miR-223-3p decreases pathogenicity of T h 17 cells
To address the CD4 + T-cell-intrinsic function of miR-223-3p in EAU, we used an IRBP-specific T-cell-induced EAU model (Fig. 3A) , in which activated T cells cause EAU when transferred into naive B6 mice (24) . For this, T cells isolated from immunized B6 mice were transfected with control or miR-223-3p inhibitor, then in vitro activated by coculturing with APC and immunized antigen. Two days later, the T cells were collected and transferred into syngeneic WT B6 mice, and the recipient mice were monitored for the development of EAU. As shown in Fig. 3B , mice that received T h 17 cells transfected with miR-223-3p inhibitor developed less severe EAU, as compared with mice that received T h 17 cells transfected with control inhibitor. Consistent with the clinical scores, massive infiltration of inflammatory cells and prominent retinal folds were observed in eyes of mice that received T h 17 cells transfected with control inhibitor relative to that in mice that received T h 17 cells with miR-223-3p inhibitor (Fig. 3C) . Compared with the mean histopathological scores of 1.68 6 0.29 in control mice, the eyes of mice given transfer of T h 17 cells with miR-223-3p inhibitor exhibited less retinal inflammation, with a mean score of 0.95 6 0.36 (P , 0.05; Fig.  3C ). Further analysis revealed that T cells isolated from mice given transfer of T cells with miR-223-3p inhibitor had dramatically lower percentages of IRBP-specific T h 17 and T h 1 cells compared with the control group (6.9 vs. 13.3% and 13.5 vs. 19%, respectively; Fig. 3D ). Correlating with the FACS data, the production of IL-17 and IFN-g was significantly decreased in the T cells from mice receiving T h 17 cells transfected with miR-223-3p inhibitor compared with that in the control group (Fig. 3E) . In addition, we found that there was a higher percentage of Foxp3 + T reg cells in splenic cells from mice given transfer of T h 17 cells transfected with miR-223-3p inhibitor than those from control mice given T h 17 cells transfected with control inhibitor (Fig. 3F ). Collectively, these results indicate that silencing miR-223-3p decreases pathogenic function of T h 17 cells and thereby ameliorates the development of EAU.
FOXO3 is a functional target of miR-223-3p
To define the mechanisms by which miR-223-3p modulates T h 17 cell responses, we used a combination of 5 different computational programs-TargetScan, PicTar, Tarbase, StarBase, and miRTarBase-to identify the putative targets of miR-223-3p (Fig. 4A) . Among the predicted targets, FOXO3, which plays an important role in regulating T-cell function, was selected for further study. As shown in Fig. 4B , 39-UTR of FOXO3 contained 1 highly conserved putative binding element for the miR-223-3p.
To determine whether FOXO3 represents direct targets of miR-223-3p, we constructed reporter plasmids by cloning the mouse WT and Mut 39-UTR of FOXO3 genes into the pMIR-Report luciferase vectors. By cotransfection of the reporter plasmids and internal control pRL-TK-Renilla luciferase plasmids with miR-223-3p mimics or control mimics, we observed that miR-223-3p suppressed the luciferase activity of the reporter containing the WT, but not the Mut 39-UTR of FOXO3 ( Fig. 4C ), suggesting that miR-223-3p specifically targets FOXO3 and regulates its expression. We next sought to examine whether miR-223-3p influenced endogenous FOXO3 expression. EL4 T cells were transfected with miR-223-3p inhibitor or control inhibitor; the expression of FOXO3 was examined by real-time qRT-PCR or Western blot. As shown in Fig.  4D , E, the mRNA and protein levels of FOXO3 were significantly increased in EL4 T cells after transfection with miR-223-3p inhibitor compared with their control, indicating that FOXO3 expression could be regulated by miR-223-3p via translational inhibition and mRNA degradation. Given the increased levels of miR-223-3p in mice with EAU and the regulation of FOXO3 expression by miR-223-3p, we investigated the expression levels of FOXO3 in T h 17 cells in EAU. The kinetic studies showed that the expression of FOXO3 dramatically decreased during EAU development (Fig. 4F ). Correlation analysis (33) revealed a negative correlation between miR-223-3p and FOXO3 expression in T h 17 cells in EAU (Fig. 4G) . These findings together suggest that FOXO3 is a functional target of miR-223-3p. 
miR-223-3p promotes pathogenic T h 17 cell responses via suppression of FOXO3
FOXO3 has been demonstrated to control the development and function of T reg cells (34, 35) . To determine the role of FOXO3 in T h 17 cells, a gain-and loss-offunction assay was performed using FOXO3 siRNA or lentivirus-mediated FOXO3 overexpression in EL4 or autoreactive T cells. As shown in Fig. 5A, B , knockdown of FOXO3 by FOXO3 siRNA significantly increased IL-17 production in autoreactive T cells. Further analysis revealed that the expression of pathogenic T h 17 cell signature genes (IL-17, ROR-gt, IL-22, GM-CSF, and IL-1R1) were significantly increased when FOXO3 was knocked down in both autoreactive T cells (Fig. 5C ) and EL4 T cells (Fig. 5D ). In addition, increased FOXO3 expression mediated by lentivirus ( Fig. 5E ) greatly inhibited the expression of IL-17, RORgt, IL-22, GM-CSF, and IL-1R1 in autoreactive T h 17 cells (Fig. 5F) , and the secretion of IL-17 was also significantly reduced after FOXO3 overexpression (Fig.  5G) . These data indicate that FOXO3 negatively controls T h 17 cell responses, acting as a suppressor of T h 17 cell development. We next examined whether the knockdown of FOXO3 counteracts decreased T h 17 cell response induced by miR-223-3p inhibitor. Cotransfection with FOXO3 siRNA, but not control siRNA, significantly rescued the decrease in mRNA and protein expression of IL-17 induced by miR-223-3p inhibitor in both EL4 T cells and autoreactive (36) . To understand the molecular mechanisms by which FOXO3 suppresses pathogenic T h 17 cell responses, we investigated the involvement of FOXO3 in IL-23R expression. We observed that knockdown of FOXO3 in autoreactive T cells resulted in a marked enhancement of IL-23R expression ( Fig. 6A) , whereas increased expression of FOXO3 had an inhibitory effect on the IL-23R expression (Fig. 6B) . These results suggest that FOXO3 is a repressor of IL-23R expression in T h 17 cells.
IL-23R regulation by miR-223-3p-FOXO3 is involved in pathogenic function of autoreactive T h 17 cells
IL-23R is critical for T h 17 cell-mediated autoimmunity in vivo
As shown in Fig. 2J , IL-23R expression was significantly reduced in miR-223-3p inhibitor-transfected T h 17 cells. In contrast, the time course analysis showed that T h 17 cells transfected with miR-223-3p mimics displayed enhanced IL-23R expression in comparison with control cells. Furthermore, the knockdown of FOXO3 rescued decreased IL-23R expression induced by miR-223-3p inhibitor in T h 17 cells (Fig. 6C) . Collectively, these data indicate that the inhibition of FOXO3 by miR-223-3p is one of the mechanisms for modulating IL-23R expression in T h 17 cells.
We next examined whether overexpression of IL-23R could rectify the defective IL-17 production induced by miR-223-3p inhibitor in T h 17 cells. Autoreactive T cells were transfected with plasmid control or IL-23R plasmid or miR-223-3p inhibitor. As shown in Fig. 6D , increased expression of IL-23R drove more IL-17 production than the control transfection group, and overexpression of IL-23R significantly reversed the decreased IL-17 production induced by miR-223-3p inhibitor. Consistent with ELISA analysis, real-time qRT-PCR analysis showed that the expression of IL-17, IL-22, and GM-CSF in miR-223-3p inhibitor-transfected T h 17 cells was partially reversed after overexpression of IL-23R ( Fig. 6E-G) . These results indicate that the reduction of IL-23R induced by miR-223-3p inhibitor is involved in the decreased pathogenic cytokine expression in T h 17 cells.
FOXO3 negatively correlated with T h 17 cell pathway in human uveitis
To extrapolate our results in mice to human subjects, we searched the Gene Expression Omnibus database for raw data from gene expression profiles in patients with uveitis and healthy volunteers, focusing on correlation of FOXO3 and the pathogenic T h 17 cell pathway. As expected, the expression of FOXO3 was down-regulated in peripheral blood mononuclear cells (PBMCs) from patients with uveitis in a clinical data set (GSE70403) (37) , whereas the expression of pathogenic T h 17 cell signature genes (including IL-17A, IL-17F, IL-1R1, IL-23R, and IL-22) was up-regulated ( Fig. 7A) . We further performed the correlation analysis between FOXO3 and T h 17 cell signature genes and found that IL-23R, IL-17A, GM-CSF, and ROR-gt correlated negatively with FOXO3 in the data sets GSE17114 (38), GSE61399 (29) , and GSE10080 ( Fig. 7B-E ). In addition, in the PBMCs of patients with active BD, human miR-223 was found to be up-regulated compared with quiescent BD (39) (Fig. 7F) . These results support that there is a potential crosstalk between the miR-223-3p-FOXO3-IL-23R axis and pathogenic T h 17 cell responses in human uveitis.
DISCUSSION
Pathogenic T h 17 cells are the critical drivers of autoimmune diseases, and functional regulators of pathogenic T h 17 cells represent potential targets for clinical diagnosis or treatment of autoimmune disorders (40) . Here, we showed that miR-223-3p positively regulated autoreactive T h 17 cell responses. Using a transferred EAU model for uveitis, we demonstrated that silencing miR-223-3p in autoreactive T cells substantially ameliorated EAU pathogenesis, consistent with the positive correlation between miR-223-3p expression and disease in patients with uveitis. Mechanistically, miR-223-3p targeted FOXO3 in autoreactive T h 17 cells. Moreover, FOXO3 negatively regulated pathogenic T h 17 cell responses partially via suppressing IL-23R expression. miR-223-3p has been studied in many fields, particularly as a participant in cancers (41) (42) (43) , ischemic heart disease (44, 45) , pulmonary arterial hypertension (46) , rheumatoid arthritis (47) , and EAE (30) . In this study, we focus on the role of miR-223-3p in pathogenic T h 17 cell responses in EAU, which has not yet been clearly illustrated. Our findings that miR-223-3p is up-regulated in autoreactive CD4 + T cells are consistent with previous results obtained in other autoimmune diseases (48) (49) (50) (51) (52) . The association among miR-223-3p, uveitis, and EAU has also been observed. miR-223 has been shown to be significantly elevated in the retina, and its levels correspond with the clinical score of the EAU in rats (14) . In the serum of patients with noninfectious uveitis, miR-223-3p was found to be significantly up-regulated compared with healthy controls (16) . In PBMCs of active BD, miR-223-3p was found to be significantly up-regulated compared with quiescent BD (39) . However, in PBMCs of patients with BD, miR-223-3p was found to be significantly down-regulated as compared with healthy controls (15) . Indeed, our present findings of miR-223-3p dysregulation are partially in line with these previous studies. It should be noted that miR-223-3p levels changed dynamically at different stages during EAU development. The expression of miR-223-3p was up-regulated at the onset and reached the maximum at the peak stage but was decreased when the disease remitted. The difference in tissue and cells types, different type of uveitis, and disease stage may account for the discrepancy in these studies.
Development of T h 17 cells is programmed by the orphan nuclear receptor ROR-gt. Our data showed that miR-223-3p overexpression in uveitogenic T cells significantly increased ROR-gt mRNA expression and IL-17 production, suggesting that miR-223-3p concurrently affects autoreactive T h 17 cell lineage commitment and function. In addition, miR-223-3p also significantly up-regulated expression of GM-CSF and IL-22, which are critical for the pathogenicity of T h 17 cells in autoimmune disease (11) . IFN-g-producing T h 1 cells also play a role in the pathogenesis of EAU (53, 54) . Here, we showed that miR-223-3p was also up-regulated in IRBP-specific T h 1 cells, and down-regulation of miR-223-3p significantly repressed IRBP-specific T h 1 cell responses in vivo. The precise mechanisms underlying the action of miR-223-3p on T h 1 cell responses in EAU are still to be identified. Given that both T h 1 and T h 17 pathogenic T cells contribute to uveitis pathogenesis, manipulation of miR-223-3p and its signal pathways may offer a new potential therapeutic strategy for uveitis.
Pathogenic T h 17 cell responses are critically regulated by DC-derived cytokines IL-1b and IL-23 (55) . IL-1b is critical for expansion of pathogenic T h 17 cells (56), and IL-23 stabilizes pathogenic T h 17 cell phenotype (7) . In this study, we observed that overexpression of miR-223-3p significantly increased the expression of IL-1b and IL-23 by DCs, suggesting miR-223-3p may create a favorable cytokine milieu that supports the generation of pathogenic T h 17 cells. Indeed, we found that miR-223-3poverexpressing DCs possessed an enhanced ability to promote the expansion of IRBP T h 17 cells and IL-17 production, indicating miR-223-3p also regulates DC-driven autoreactive T h 17 cell responses. Our results here are further supported by a previous report (ref. 30) showing that miR-223 enhanced myeloid DC-induced activation of pathogenic T h 17 cells in EAE.
In a subsequent study, we found that miR-223-3p and FOXO3 displayed an inverse pattern of expression in EAU, and we identified FOXO3 as a target gene of miR-223-3p in autoreactive CD4 + T cells. In agreement with our findings, (34) . High expression of miR-223 has been shown to be associated with lower numbers of T reg cells in tobacco smokers (58) . In this study, we observed that spleen cells from mice receiving T cells transfected with miR-223-3p inhibitor displayed a higher percentage of T reg cells, suggesting decreased miR-223-3p may favor the generation of T reg cells. Although T h 17 and T reg cells play opposite roles in the regulation of autoimmunity, these 2 subsets can interconvert under specific conditions (59-61). Park et al. (62) demonstrated that FOXO3 ablation promotes T reg -to-T h 17-like cell conversion, suggesting FOXO3 may function as an intrinsic modulator in T cells that decides between the T h 17 and T reg cell choices. Our studies here suggest that this lineage choice is also influenced by miR-223-3p: miR-223-3p biases T cells toward T h 17 cell lineage but inhibits T reg cell differentiation by suppressing FOXO3 expression. Therefore, we proposed that by modulating FOXO3 expression, miR-223-3p might be a posttranscriptional regulator controlling T h 17-to-T reg cell plasticity in EAU. FOXO3 also drives pathogenic T h 1 cell differentiation via inducing eomeseodermin expression in EAE, and deletion of FOXO3 ameliorates EAE (21) . Further studies are needed to investigate the impact of FOXO3 on IRBP T h 1 cell responses and examine its role in modulation of EAU disease severity.
IL-23R is a key molecule of pathogenic T h 17 cell signatures (63) . In the present study, we focused on IL-23R as key target of FOXO3 to explain its regulation on T h 17 cell pathogenic function. We found that overexpression of FOXO3 in T h 17 cells led to decreased IL-23R expression, indicating that FOXO3 negatively regulated the expression of IL-23R in T h 17 cells. ROR-gt induces the expression of IL-23R by binding directly to the Il-23R promoter in T h 17 cells (64). We found 1 putative FOXO3 binding element close to the RORgt binding region on the mouse Il-23R locus (Supplemental Fig. S1A, B) , indicating that FOXO3 might inhibit IL-23R expression via interference of ROR-gt activity in uveitogenic T h 17 cells and therefore control the pathogenicity of T h 17 cells. Of note, miR-223-3p directly targeted FOXO3 to promote IL-17 production, silencing FOXO3 enhanced IL-23R expression, and IL-23 treatment significantly enhanced the expression of miR-223-3p and IL-23R (36) . Therefore, we proposed that miR-223-3p, together with IL-23, FOXO3, and IL-23R may form a positive feedback loop to stabilize the pathogenic T h 17 cell phenotype and contribute to constant IL-17 production in EAU (Fig. 8 ). (65) . Various studies have been undertaken to reveal the regulatory network of miRs in the regulation of pathogenic T h 17 cells in autoimmunity (65) (66) (67) (68) (69) . Our study here adds another wrinkle to the relationship between miRs and pathogenic T h 17 cells. Specifically, we have demonstrated that the suppression of FOXO3 via miR-223-3p is an important mechanism by which T h 17 cells acquire pathogenic function in EAU. Thus, the miR-223-3p-FOXO3 axis may be an important therapeutic target for uveitis. 
